Inhalable nanoparticles to the heart
Inhalable nanoparticles to the heart
Nanotechnology meets cardiology
Nanotechnology meets cardiology
A drug-delivery as simple as breathing
A drug-delivery as simple as breathing
Background
Our Goal
Consortium

THE BREATHING HEART

1. Nanoparticle production
Biocompatible and biodegradable nanoparticles can self-assemble and encapsulate drugs
2. Inhalation
Nanoparticles are transformed into an inhalable coarser dry powder that can reach the airways.
3. Crossing the pulmonary barrier
Nanoparticles can cross the alveolar-capillary barrier, rapidly reaching the heart
4. One target: the heart
The heart specificity is ensured thanks to chemical and magnetic guidance

THE CONSORTIUM

99
Research groups
99
SMEs
99
Pharma Company
99
Industries

A multidisciplinary team

CUPIDO multidisciplinary consortium gathers a heterogeneous array of expertise and pulls together cutting-edge research with pre-clinical experience and industrial manufacturing. Indeed the 12 CUPIDO partners can cover the complete chain that brings an idea into a feasible product and cover expertise in:

  • cardiovascular and nanotechnology research
  • bioengineering and molecular imaging
  • pulmonology and lung cell biology
  • in silico computational models
  • wearable electronics
  • drug delivery solutions
  • pharmaceutical products.
CUPIDO’s videos

NEWS

A reliable process to produce nanoparticles from the lab to industrial scale.
A reliable process to produce nanoparticles from the lab to industrial scale.
October 20, 2020
Our partners from CNR, PLUMESTARS and FINCERAMICA have just published a new paper in the Special Issue of the Journal Crystals. In the article, the CUPIDO team applies a promising nanopartic...
Mediated guidance of CaP to the heart
Mediated guidance of CaP to the heart
June 10, 2020
CUPIDO since its beginning has worked to develop synergistic targeting techniques that could maximize nanoparticle delivery to the heart. One of the options considered by the project is the ...
Therapeutic efficacy of the ultimate formulation of Cupido nanoparticles
Therapeutic efficacy of the ultimate formulation of Cupido nanoparticles
April 14, 2020
Cupido’s partner CNR, Finceramica and Plumestars have closely collaborated during this period to establish the first proof of concept of the therapeutic efficacy of the ultimate formulation
LinkedIn
Share